OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic regulation in lung cancer
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Methylation Biomarkers of Lung Cancer Risk: A Systematic Review and Meta-Analysis
Jacopo Dolcini, Manuela Chiavarini, Giorgio Firmani, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 690-690
Open Access | Times Cited: 1

The multipotential effect of microbiome in lung cancer development and progression
Nastaran Karimi, Angélica Baca De Anda, Rachel Yang, et al.
International review of cell and molecular biology (2025)
Closed Access

Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access

Personalized Approaches to Lung Cancer Treatment: A Review of Targeted Therapies, Pharmacogenomics, and Combination Strategies
M. Tabrizi Namini, G. Bhagya, Manjari Sharma
Aspects of Molecular Medicine (2025), pp. 100073-100073
Open Access

Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
Michael S. Oh, Jensen Abascal, Austin K. Rennels, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1027-1027
Open Access

Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4

Fabrication of etoposide-loaded folic-acid-clocked mesoporous nanoparticles: Investigation of lung cancer proliferation and induction of apoptosis and ferroptosis
Wanwan Chen, Xuezhen Cao, Songsong Wu, et al.
Process Biochemistry (2024) Vol. 141, pp. 19-29
Closed Access | Times Cited: 3

Targeting RET alterations in non-small cell lung cancer
Go Nishikawa, Mark Klein
Current Problems in Cancer (2024) Vol. 49, pp. 101074-101074
Closed Access | Times Cited: 2

Epigenetic modulation of cytokine expression in Mycobacterium tuberculosis-infected monocyte derived-dendritic cells: Implications for tuberculosis diagnosis
Maryam Meskini, Mohammad Saber Zamani, Amir Amanzadeh, et al.
Cytokine (2024) Vol. 181, pp. 156693-156693
Closed Access | Times Cited: 2

Sensitive detection of miR-9 in human serum: An electrochemical approach utilizing robust gold nanostructures for early diagnosis of lung cancer
Zahra Sahafnejad, Hadi Hashemzadeh, Abdollah Allahverdi, et al.
Talanta Open (2023) Vol. 8, pp. 100272-100272
Open Access | Times Cited: 6

Machine learning-based approaches for ubiquitination site prediction in human proteins
Mahdi Pourmirzaei, Shahin Ramazi, Farzaneh Esmaili, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
(2024)
Open Access | Times Cited: 1

Tumor‐associated exosomes in cancer progression and therapeutic targets
Xiaomin Liu, Fan Wu, Wei Pan, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 1

A combined model of circulating tumor DNA methylated SHOX2/SCT/HOXA7 and clinical features facilitates the discrimination of malignant from benign pulmonary nodules
Lu He, Biao Zhang, Chu Zhou, et al.
Lung Cancer (2024) Vol. 199, pp. 108064-108064
Closed Access | Times Cited: 1

Decoding the complex web: Cellular and molecular interactions in the lung tumor microenvironment
Bonnie Issa, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of drug targeting (2024), pp. 1-44
Closed Access | Times Cited: 1

Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer
Martina Montanari, Maria Meringolo, Ilham El Atiallah, et al.
Interdisciplinary cancer research (2024)
Closed Access

SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter
Anja Kafka, Nives Pećina‐Šlaus, Denis Drmić, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access

Histone modification and personalized epigenomics in cancer
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, et al.
Elsevier eBooks (2024), pp. 429-473
Closed Access

DNA Methylation Analysis Identifies Clinically Relevant Lung Adenocarcinoma Subgroups
Oluwadamilare I. Afolabi
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity
Raluca Munteanu, Cristian Moldovan, Adrian Bogdan Țigu, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 4, pp. 488-506
Open Access

Page 1 - Next Page

Scroll to top